Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leslie Amass

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Cardiology and Therapy|May 18, 2022
Sex Differences in Wild-Type Transthyretin Amyloidosis: An Analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS)Courtney M Campbell, Samantha LoRusso, Angela Dispenzieri, et al.
Addiction (Abingdon, England)|July 14, 2011
A prospective, randomized, multicenter acceptability and safety study of direct buprenorphine/naloxone induction in heroin-dependent individualsLeslie Amass, Vilma Pukeleviciene, Emilis Subata, et al.
JACC. Advances|August 6, 2024
Age- and Sex-Related Differences in Patients With Wild-Type Transthyretin Amyloidosis: Insights From THAOSNerea Mora-Ayestaran, Angela Dispenzieri, Arnt V Kristen, et al.
Neurology and Therapy|July 31, 2021
A Descriptive Analysis of ATTR Amyloidosis in Spain from the Transthyretin Amyloidosis Outcomes SurveyJuan González-Moreno, Inés Losada-López, Eugenia Cisneros-Barroso, et al.
Cardiology and Therapy|December 20, 2023
Clinical and Genotype Characteristics and Symptom Migration in Patients With Mixed Phenotype Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes SurveyJuan González-Moreno, Angela Dispenzieri, Martha Grogan, et al.
JACC. Heart Failure|August 15, 2021
Sex-Related Risk of Cardiac Involvement in Hereditary Transthyretin Amyloidosis: Insights From THAOSAngelo Giuseppe Caponetti, Claudio Rapezzi, Christian Gagliardi, et al.
Orphanet Journal of Rare Diseases|June 18, 2022
Clinical and genetic profile of patients enrolled in the Transthyretin Amyloidosis Outcomes Survey (THAOS): 14-year updateAngela Dispenzieri, Teresa Coelho, Isabel Conceição, et al.
Addiction (Abingdon, England)|July 27, 2005
A multi-center randomized trial of buprenorphine-naloxone versus clonidine for opioid detoxification: findings from the National Institute on Drug Abuse Clinical Trials NetworkWalter Ling, Leslie Amass, Steve Shoptaw, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 22, 2022
Characteristics of patients with autonomic dysfunction in the Transthyretin Amyloidosis Outcomes Survey (THAOS)Fabio A Barroso, Teresa Coelho, Angela Dispenzieri, et al.
JACC. Cardiooncology|November 3, 2021
Temporal Trends of Wild-Type Transthyretin Amyloid Cardiomyopathy in the Transthyretin Amyloidosis Outcomes SurveyJose Nativi-Nicolau, Alfonso Siu, Angela Dispenzieri, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Cardiology and Therapy|May 18, 2022
Sex Differences in Wild-Type Transthyretin Amyloidosis: An Analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS)Courtney M Campbell, Samantha LoRusso, Angela Dispenzieri, et al.
Addiction (Abingdon, England)|July 14, 2011
A prospective, randomized, multicenter acceptability and safety study of direct buprenorphine/naloxone induction in heroin-dependent individualsLeslie Amass, Vilma Pukeleviciene, Emilis Subata, et al.
JACC. Advances|August 6, 2024
Age- and Sex-Related Differences in Patients With Wild-Type Transthyretin Amyloidosis: Insights From THAOSNerea Mora-Ayestaran, Angela Dispenzieri, Arnt V Kristen, et al.
Neurology and Therapy|July 31, 2021
A Descriptive Analysis of ATTR Amyloidosis in Spain from the Transthyretin Amyloidosis Outcomes SurveyJuan González-Moreno, Inés Losada-López, Eugenia Cisneros-Barroso, et al.
Cardiology and Therapy|December 20, 2023
Clinical and Genotype Characteristics and Symptom Migration in Patients With Mixed Phenotype Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes SurveyJuan González-Moreno, Angela Dispenzieri, Martha Grogan, et al.
JACC. Heart Failure|August 15, 2021
Sex-Related Risk of Cardiac Involvement in Hereditary Transthyretin Amyloidosis: Insights From THAOSAngelo Giuseppe Caponetti, Claudio Rapezzi, Christian Gagliardi, et al.
Orphanet Journal of Rare Diseases|June 18, 2022
Clinical and genetic profile of patients enrolled in the Transthyretin Amyloidosis Outcomes Survey (THAOS): 14-year updateAngela Dispenzieri, Teresa Coelho, Isabel Conceição, et al.
Addiction (Abingdon, England)|July 27, 2005
A multi-center randomized trial of buprenorphine-naloxone versus clonidine for opioid detoxification: findings from the National Institute on Drug Abuse Clinical Trials NetworkWalter Ling, Leslie Amass, Steve Shoptaw, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 22, 2022
Characteristics of patients with autonomic dysfunction in the Transthyretin Amyloidosis Outcomes Survey (THAOS)Fabio A Barroso, Teresa Coelho, Angela Dispenzieri, et al.
JACC. Cardiooncology|November 3, 2021
Temporal Trends of Wild-Type Transthyretin Amyloid Cardiomyopathy in the Transthyretin Amyloidosis Outcomes SurveyJose Nativi-Nicolau, Alfonso Siu, Angela Dispenzieri, et al.
Pageof 5